通过准长非编码RNA来治疗安吉尔曼综合征
Linyan Meng1, Amanda J Ward2, Seung Chun2
1Department of Molecular and Human Genetics, Baylor College of Medicine, and Texas Children's Hospital, Houston, Texas 77030, USA.
Nature
|December 4, 2014
概括
研究人员开发了一种针对安吉尔曼综合征的新型基因疗法,使用反感性寡核化物 (ASOs) 来降低UBE3A-ATS并激活父性UBE3A基因,为这种神经发育障碍提供了潜在的治疗方法.
科学领域:
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 安吉尔曼综合征是一种神经发育障碍,由母亲的UBE3A基因缺陷引起.
- 完整的父亲UBE3A等位基因被UBE3A反意义转录 (UBE3A-ATS) 沉默.
- 目前针对安吉尔曼综合征的治疗方法缺乏基因特异性.
研究的目的:
- 开发一种针对安吉尔曼综合征的基因特异性治疗干预措施.
- 调查减少UBE3A-ATS以恢复父亲UBE3A表达的潜力.
- 评估反感性寡核酸 (ASOs) 在治疗安吉尔曼综合征方面的疗效.
主要方法:
- 开发出反感性寡核化物 (ASOs) 来准和减少UBE3A-ATS.
- 在安吉尔曼综合征小鼠模型中实验室和体内给予ASO.
- 评估了UBE3A-ATS的减少,父亲的UBE3A表达和UBE3A蛋白的恢复.
- 在接受治疗的小鼠模型中评估认知缺陷.
主要成果:
- ASO治疗特别降低了UBE3A-ATS水平.
- 在神经元中观察到父亲Ube3a等位基因的持续解除沉默.
- 在Angelman综合征小鼠模型中,UBE3A蛋白的部分恢复得到了实现.
- 在接受治疗的小鼠中,观察到一些认知缺陷的改善.
结论:
- 通过ASO调节UBE3A-ATS是一种可行的策略,可以激活父亲的UBE3A表达.
- 这种方法为安吉尔曼综合征提供了潜在的基因特异性治疗干预.
- 需要进一步的研究来证实表型纠正和临床疗效.
更多相关视频
07:02Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
Published on: May 11, 2018
14.6K
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
8.2K
相关概念视频
02:39lncRNA - Long Non-coding RNAs
10.2K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
02:39lncRNA - Long Non-coding RNAs
3.9K
3.9K
02:15Experimental RNAi
8.4K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.4K
02:30siRNA - Small Interfering RNAs
19.1K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.1K
02:18Alternative RNA Splicing
27.6K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
27.6K
01:23RNA Interference
29.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
29.0K